(Q41023694)

25 September 2017

1 reference

title

Acute myocardial infarction, reperfusion injury, and intravenous magnesium therapy: basic concepts and clinical implications (English)

1 reference

25 September 2017

1 reference

Steurer G

1 reference

25 September 2017

Yang P

1 reference

25 September 2017

Rao V

1 reference

25 September 2017

Mohl W

1 reference

25 September 2017

Glogar D

1 reference

25 September 2017

Smetana R

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

25 September 2017

published in

American Heart Journal

1 reference

25 September 2017

volume

132

1 reference

25 September 2017

issue

2 Pt 2 Su

1 reference

25 September 2017

page(s)

478-82; discussion 496-502

1 reference

Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommitte

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Primary angioplasty in myocardial infarction: Assessment of improved myocardial perfusion with technetium-99m isonitrile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Outcome of patients with acute myocardial infarction who are ineligible for thrombolytic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Myocardial 'stunning' in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Demonstration of myocardial reperfusion injury in humans: results of a pilot study utilizing acute coronary angioplasty with perfluorochemical in anterior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Exacerbation of reperfusion arrhythmias by sudden oxidant stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Early afterdepolarizations induced in vivo by reperfusion of ischemic myocardium. A possible mechanism for reperfusion arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Reduction in experimental infarct size by recombinant human superoxide dismutase: insights into the pathophysiology of reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Ultrastructural damage associated with reoxygenation of the anoxic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Marked reduction in myocardial infarct size due to prolonged infusion of an antioxidant during reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Does reperfusion injury exist in humans?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Free-radical activity after primary coronary angioplasty in acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Effects of superoxide dismutase on reperfusion arrhythmias and left ventricular function in patients undergoing thrombolysis for anterior wall acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Neutrophil-induced injury of rat pulmonary alveolar epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Pathophysiology and pathogenesis of stunned myocardium. Depressed Ca2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Cellular mechanisms of myocardial stunning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Excitation-contraction coupling in postischemic myocardium. Does failure of activator Ca2+ transients underlie stunning?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Optimal calcium concentration in the initial reperfusate for post-ischemic myocardial performance (calcium concentration during reperfusion)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Contractile dysfunction and ATP depletion after transient calcium overload in perfused ferret hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Interaction of the sympathetic nervous system and electrolytes in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Possible pharmacological actions of magnesium in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Endothelium-dependent relaxation in coronary arteries requires magnesium ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Hemodynamic effects of magnesium sulfate on the normal human heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Magnesium treatment of ventricular arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Mechanism of increased erythrocyte membrane fluidity during magnesium deficiency in weanling rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Importance of magnesium chloride repletion after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Acute extracellular magnesium deficiency and myocardial tolerance to ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Myocardial tissue concentrations of magnesium and potassium in men dying suddenly from ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Lymphocyte Potassium and Magnesium Concentrations as Prognostic Factors after Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Tissue-specific modulation of the mitochondrial calcium uniporter by magnesium ions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Reperfusion of the ischemic myocardium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Magnesium: Nature's physiologic calcium blocker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Effects of an increase in intracellular free [Mg2+] after myocardial stunning on sarcoplasmic reticulum Ca2+ transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Beneficial effect of magnesium sulfate in acute myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Intravenous magnesium in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

One-year death rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Intravenous magnesium in acute myocardial infarction. An effective, safe, simple, and inexpensive intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Randomized trials of magnesium in acute myocardial infarction: big numbers do not tell the whole story.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Reexamination of magnesium infusions in myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Reduction of infarct size induced by pressure-controlled intermittent coronary sinus occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Effects of pressure-controlled intermittent coronary sinus occlusion on regional ischemic myocardial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

Clinical evaluation of pressure-controlled intermittent coronary sinus occlusion: randomized trial during coronary artery surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990339-7

10.1016/S0002-8703(96)90339-7

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference